158 related articles for article (PubMed ID: 32542645)
1. A dynamic mutational landscape associated with an inter-regionally diverse immune response in malignant rhabdoid tumour.
Yasui H; Valind A; Karlsson J; Pietras C; Jansson C; Wille J; Romerius P; Backman T; Gisselsson D
J Pathol; 2020 Sep; 252(1):22-28. PubMed ID: 32542645
[TBL] [Abstract][Full Text] [Related]
2. Tumor mutation burden, DNA mismatch repair status and checkpoint immunotherapy markers in primary and relapsed malignant rhabdoid tumors.
Abro B; Kaushal M; Chen L; Wu R; Dehner LP; Pfeifer JD; He M
Pathol Res Pract; 2019 Jun; 215(6):152395. PubMed ID: 31047727
[TBL] [Abstract][Full Text] [Related]
3. Subclassification of epithelioid sarcoma with potential therapeutic impact.
Haefliger S; Chervova O; Davies C; Nottley S; Hargreaves S; Sumathi VP; Amary F; Tirabosco R; Pillay N; Beck S; Flanagan AM; Lyskjaer I
J Pathol; 2023 Aug; 260(4):368-375. PubMed ID: 37316954
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
Liu NQ; Paassen I; Custers L; Zeller P; Teunissen H; Ayyildiz D; He J; Buhl JL; Hoving EW; van Oudenaarden A; de Wit E; Drost J
Nat Commun; 2023 Dec; 14(1):7762. PubMed ID: 38040699
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.
Shirai R; Osumi T; Terashima K; Kiyotani C; Uchiyama M; Tsujimoto S; Yoshida M; Yoshida K; Uchiyama T; Tomizawa D; Shioda Y; Sekiguchi M; Watanabe K; Keino D; Ueno-Yokohata H; Ohki K; Takita J; Ito S; Deguchi T; Kiyokawa N; Ogiwara H; Hishiki T; Ogawa S; Okita H; Matsumoto K; Yoshioka T; Kato M
Eur J Hum Genet; 2020 Aug; 28(8):1124-1128. PubMed ID: 32218533
[TBL] [Abstract][Full Text] [Related]
6. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
7. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
[TBL] [Abstract][Full Text] [Related]
8. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours.
Custers L; Khabirova E; Coorens THH; Oliver TRW; Calandrini C; Young MD; Vieira Braga FA; Ellis P; Mamanova L; Segers H; Maat A; Kool M; Hoving EW; van den Heuvel-Eibrink MM; Nicholson J; Straathof K; Hook L; de Krijger RR; Trayers C; Allinson K; Behjati S; Drost J
Nat Commun; 2021 Mar; 12(1):1407. PubMed ID: 33658498
[TBL] [Abstract][Full Text] [Related]
10. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.
Chun HE; Johann PD; Milne K; Zapatka M; Buellesbach A; Ishaque N; Iskar M; Erkek S; Wei L; Tessier-Cloutier B; Lever J; Titmuss E; Topham JT; Bowlby R; Chuah E; Mungall KL; Ma Y; Mungall AJ; Moore RA; Taylor MD; Gerhard DS; Jones SJM; Korshunov A; Gessler M; Kerl K; Hasselblatt M; Frühwald MC; Perlman EJ; Nelson BH; Pfister SM; Marra MA; Kool M
Cell Rep; 2019 Nov; 29(8):2338-2354.e7. PubMed ID: 31708418
[TBL] [Abstract][Full Text] [Related]
11. Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma.
Guo L; Bi X; Li Y; Wen L; Zhang W; Jiang W; Ma J; Feng L; Zhang K; Shou J
J Pathol; 2020 May; 251(1):26-37. PubMed ID: 32073142
[TBL] [Abstract][Full Text] [Related]
12. Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors.
Sabatella M; Mantere T; Waanders E; Neveling K; Mensenkamp AR; van Dijk F; Hehir-Kwa JY; Derks R; Kwint M; O'Gorman L; Tropa Martins M; Gidding CE; Lequin MH; Küsters B; Wesseling P; Nelen M; Biegel JA; Hoischen A; Jongmans MC; Kuiper RP
J Pathol; 2021 Oct; 255(2):202-211. PubMed ID: 34231212
[TBL] [Abstract][Full Text] [Related]
13. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
[TBL] [Abstract][Full Text] [Related]
14. Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.
Darr J; Klochendler A; Isaac S; Geiger T; Eden A
Mol Cancer; 2015 Sep; 14():167. PubMed ID: 26370283
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis.
Kinoshita Y; Shiratsuchi H; Tamiya S; Oshiro Y; Hachitanda Y; Oda Y; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2001; 127(6):351-8. PubMed ID: 11414195
[TBL] [Abstract][Full Text] [Related]
16. Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
Vokuhl C; Oyen F; Häberle B; von Schweinitz D; Schneppenheim R; Leuschner I
Genes Chromosomes Cancer; 2016 Dec; 55(12):925-931. PubMed ID: 27356182
[TBL] [Abstract][Full Text] [Related]
17. Malignant rhabdoid tumor of the liver presented with initial tumor rupture.
Kachanov D; Teleshova M; Kim E; Dobrenkov K; Moiseenko R; Usychkina A; Filin A; Semenkov A; Mitrofanova A; Konovalov D; Shamanskaya T; Novichkova G; Varfolomeeva S
Cancer Genet; 2014 Sep; 207(9):412-4. PubMed ID: 24894493
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
[TBL] [Abstract][Full Text] [Related]
19. Novel Two MRT Cell Lines Established from Multiple Sites of a Synchronous MRT Patient.
Kuwahara Y; Iehara T; Ichise E; Katsumi Y; Ouchi K; Tsuchiya K; Miyachi M; Konishi E; Sasajima H; Nakamura S; Fumino S; Tajiri T; Johann PD; FrÜhwald MC; Yoshida T; Okuda T; Hosoi H
Anticancer Res; 2020 Nov; 40(11):6159-6170. PubMed ID: 33109553
[TBL] [Abstract][Full Text] [Related]
20. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
